Alzheimer disease features neurobiological changes long before the first symptoms of cognitive decline. Results from a new study to define the orderly changes of markers of amyloidosis and neurodegeneration over the disease course will assist the development of biomarker-based protocols for early diagnosis, and disease-modifying drugs.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Quantitative electroencephalographic changes and hippocampal atrophy in diabetic patients with mild cognitive impairment in Ismailia region
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery Open Access 01 June 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jack, C. R. Jr et al. Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. Arch. Neurol. http://dx.doi.org/10.1001/archneurol.2011.3405.
Dubois, B. et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 6, 734–746 (2007).
Jack, C. R. Jr et al. Introduction to the recommendations from the National Institute on Aging-–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 257–262 (2011).
Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P. & Kivipelto, M. Alzheimer's disease: clinical trials and drug development. Lancet Neurol. 9, 702–716 (2010).
Jack, C. R. Jr et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119–128 (2010).
Lorenzi, M., Ayache, N., Frisoni, G. B. & Pennec, X. Mapping the effects of Aβ levels on the longitudinal changes in healthy aging: hierarchical modeling based on stationary velocity fields. In Proc. 14th International Conference on Medical Image Computing and Computer-Assisted Intervention (eds Fichtinger, G. et al.) 663–670 (Springer-Verlag, Berlin/Heidelberg, 2011).
Frisoni, G. B. & Weiner, M. W. Alzheimer's Disease Neuroimaging Initiative special issue. Neurobiol. Aging 31, 1259–1262 (2010).
Frisoni, G. B., Fox, N. C., Jack, C. R. Jr, Scheltens, P. & Thompson, P. M. The clinical use of structural MRI in Alzheimer disease. Nat. Rev. Neurol. 6, 67–77 (2010).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Frisoni, G. Biomarker trajectories across stages of Alzheimer disease. Nat Rev Neurol 8, 299–300 (2012). https://doi.org/10.1038/nrneurol.2012.81
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2012.81
This article is cited by
-
Quantitative electroencephalographic changes and hippocampal atrophy in diabetic patients with mild cognitive impairment in Ismailia region
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery (2018)
